Table of Contents

1 Study Coverage

• 1.1 Etoposide Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Etoposide Market Size Growth Rate by Product
  • 1.4.2 Etoposide for Injection
  • 1.4.3 Etoposide for Oral Use
• 1.5 Market by End User
  • 1.5.1 Global Etoposide Market Size Growth Rate by End User
  • 1.5.2 Small Cell Lung Cancer
  • 1.5.3 Testicular Cancer
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Etoposide Market Size
  • 2.1.1 Global Etoposide Revenue 2014-2025
  • 2.1.2 Global Etoposide Sales 2014-2025
• 2.2 Etoposide Growth Rate by Regions
  • 2.2.1 Global Etoposide Sales by Regions
  • 2.2.2 Global Etoposide Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Etoposide Sales by Manufacturers
  • 3.1.1 Etoposide Sales by Manufacturers
  • 3.1.2 Etoposide Sales Market Share by Manufacturers
  • 3.1.3 Global Etoposide Market Concentration Ratio (CR5 and HHI)
• 3.2 Etoposide Revenue by Manufacturers
  • 3.2.1 Etoposide Revenue by Manufacturers (2014-2019)
  • 3.2.2 Etoposide Revenue Share by Manufacturers (2014-2019)
• 3.3 Etoposide Price by Manufacturers
• 3.4 Etoposide Manufacturing Base Distribution, Product Types
  • 3.4.1 Etoposide Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Etoposide Product Type
  • 3.4.3 Date of International Manufacturers Enter into Etoposide Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Etoposide Sales by Product
• 4.2 Global Etoposide Revenue by Product
• 4.3 Etoposide Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Etoposide Breakdown Data by End User

6 North America

• 6.1 North America Etoposide by Countries
  • 6.1.1 North America Etoposide Sales by Countries
  • 6.1.2 North America Etoposide Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Etoposide by Product
• 6.3 North America Etoposide by End User

7 Europe

• 7.1 Europe Etoposide by Countries
  • 7.1.1 Europe Etoposide Sales by Countries
  • 7.1.2 Europe Etoposide Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Etoposide by Product
• 7.3 Europe Etoposide by End User

8 Asia Pacific

• 8.1 Asia Pacific Etoposide by Countries
  • 8.1.1 Asia Pacific Etoposide Sales by Countries
  • 8.1.2 Asia Pacific Etoposide Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Etoposide by Product
• 8.3 Asia Pacific Etoposide by End User

9 Central & South America

• 9.1 Central & South America Etoposide by Countries
  • 9.1.1 Central & South America Etoposide Sales by Countries
  • 9.1.2 Central & South America Etoposide Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Etoposide by Product
• 9.3 Central & South America Etoposide by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Etoposide by Countries
  • 10.1.1 Middle East and Africa Etoposide Sales by Countries
  • 10.1.2 Middle East and Africa Etoposide Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Etoposide by Product
• 10.3 Middle East and Africa Etoposide by End User

11 Company Profiles

• 11.1 Shyndec Pharmaceutical
  • 11.1.1 Shyndec Pharmaceutical Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Shyndec Pharmaceutical Etoposide Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Shyndec Pharmaceutical Etoposide Products Offered
  • 11.1.5 Shyndec Pharmaceutical Recent Development
• 11.2 Qilu Antibiotics
  • 11.2.1 Qilu Antibiotics Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Qilu Antibiotics Etoposide Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Qilu Antibiotics Etoposide Products Offered
  • 11.2.5 Qilu Antibiotics Recent Development
• 11.3 Gansu Fuzheng
  • 11.3.1 Gansu Fuzheng Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Gansu Fuzheng Etoposide Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Gansu Fuzheng Etoposide Products Offered
  • 11.3.5 Gansu Fuzheng Recent Development
• 11.4 KPC Pharmaceuticals
  • 11.4.1 KPC Pharmaceuticals Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 KPC Pharmaceuticals Etoposide Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 KPC Pharmaceuticals Etoposide Products Offered
  • 11.4.5 KPC Pharmaceuticals Recent Development
• 11.5 China Resources Double Crane Pharmaceutical
  • 11.5.1 China Resources Double Crane Pharmaceutical Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 China Resources Double Crane Pharmaceutical Etoposide Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 China Resources Double Crane Pharmaceutical Etoposide Products Offered
  • 11.5.5 China Resources Double Crane Pharmaceutical Recent Development
• 11.6 Nippon Kayaku
  • 11.6.1 Nippon Kayaku Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Nippon Kayaku Etoposide Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Nippon Kayaku Etoposide Products Offered
  • 11.6.5 Nippon Kayaku Recent Development
• 11.7 Accord Healthcare
  • 11.7.1 Accord Healthcare Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Accord Healthcare Etoposide Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Accord Healthcare Etoposide Products Offered
  • 11.7.5 Accord Healthcare Recent Development
• 11.8 Teva Pharmaceutical
  • 11.8.1 Teva Pharmaceutical Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Teva Pharmaceutical Etoposide Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Teva Pharmaceutical Etoposide Products Offered
  • 11.8.5 Teva Pharmaceutical Recent Development
• 11.9 Mylan
  • 11.9.1 Mylan Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Mylan Etoposide Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Mylan Etoposide Products Offered
  • 11.9.5 Mylan Recent Development

12 Future Forecast

• 12.1 Etoposide Market Forecast by Regions
  • 12.1.1 Global Etoposide Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Etoposide Revenue Forecast by Regions 2019-2025
• 12.2 Etoposide Market Forecast by Product
  • 12.2.1 Global Etoposide Sales Forecast by Product 2019-2025
  • 12.2.2 Global Etoposide Revenue Forecast by Product 2019-2025
• 12.3 Etoposide Market Forecast by End User
• 12.4 North America Etoposide Forecast
• 12.5 Europe Etoposide Forecast
• 12.6 Asia Pacific Etoposide Forecast
• 12.7 Central & South America Etoposide Forecast
• 12.8 Middle East and Africa Etoposide Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Etoposide Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

The global Etoposide market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Etoposide market based on company, product type, end user and key regions.

This report studies the global market size of Etoposide in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Etoposide in these regions.
This research report categorizes the global Etoposide market by top players/brands, region, type and end user. This report also studies the global Etoposide market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Shyndec Pharmaceutical
Qilu Antibiotics
Gansu Fuzheng
KPC Pharmaceuticals
China Resources Double Crane Pharmaceutical
Nippon Kayaku
Accord Healthcare
Teva Pharmaceutical
Mylan

Market size by Product
Etoposide for Injection
Etoposide for Oral Use
Market size by End User
Small Cell Lung Cancer
Testicular Cancer

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Etoposide market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Etoposide market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Etoposide companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Etoposide submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Etoposide are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Etoposide market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.